In vitro Activity of Sparfloxacin (CI-978), a New Broad-Spectrum Fluoroquinolone

Chemotherapy ◽  
1992 ◽  
Vol 38 (2) ◽  
pp. 99-106 ◽  
Author(s):  
Hussain Qadri ◽  
Yoshio Ueno ◽  
Joyce Burns ◽  
Edna Almodovar ◽  
Nada Rabea
2007 ◽  
Vol 52 (1) ◽  
pp. 77-84 ◽  
Author(s):  
Catherine Clark ◽  
Kathy Smith ◽  
Lois Ednie ◽  
Tatiana Bogdanovich ◽  
Bonifacio Dewasse ◽  
...  

ABSTRACT DC-159a yielded MICs of ≤1 μg/ml against 316 strains of both quinolone-susceptible and -resistant pneumococci (resistance was defined as a levofloxacin MIC ≥4 μg/ml). Although the MICs for DC-159a against quinolone-susceptible pneumococci were a few dilutions higher than those of gemifloxacin, the MICs of these two compounds against 28 quinolone-resistant pneumococci were identical. The DC-159a MICs against quinolone-resistant strains did not appear to depend on the number or the type of mutations in the quinolone resistance-determining region. DC-159a, as well as the other quinolones tested, was bactericidal after 24 h at 2× MIC against 11 of 12 strains tested. Two of the strains were additionally tested at 1 and 2 h, and DC-159a at 4× MIC showed significant killing as early as 2 h. Multistep resistance selection studies showed that even after 50 consecutive subcultures of 10 strains in the presence of sub-MICs, DC-159a produced only two mutants with maximum MICs of 1 μg/ml.


1992 ◽  
Vol 36 (1) ◽  
pp. 100-107 ◽  
Author(s):  
K Andries ◽  
B Dewindt ◽  
J Snoeks ◽  
R Willebrords ◽  
K van Eemeren ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document